167 related articles for article (PubMed ID: 12878505)
1. Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys.
Lin CC; Luu K; Lourenco D; Yeh LT
Antimicrob Agents Chemother; 2003 Aug; 47(8):2458-63. PubMed ID: 12878505
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of [(14)C]ribavirin in rats and cynomolgus monkeys.
Lin CC; Yeh LT; Luu T; Lourenco D; Lau JY
Antimicrob Agents Chemother; 2003 Apr; 47(4):1395-8. PubMed ID: 12654676
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
Lin CC; Philips L; Xu C; Yeh LT
J Clin Pharmacol; 2004 Mar; 44(3):265-75. PubMed ID: 14973309
[TBL] [Abstract][Full Text] [Related]
4. Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals.
Lin CC; Yeh LT; Vitarella D; Hong Z
Antivir Chem Chemother; 2003 May; 14(3):145-52. PubMed ID: 14521331
[TBL] [Abstract][Full Text] [Related]
5. Absorption, metabolism, and excretion of [14C]viramidine in humans.
Lin CC; Xu C; Zhu N; Yeh LT
Antimicrob Agents Chemother; 2006 Jul; 50(7):2368-73. PubMed ID: 16801414
[TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics and metabolism of [14C]remofovir in rats and cynomolgus monkeys.
Lin CC; Xu C; Zhu N; Lourenco D; Yeh LT
Antimicrob Agents Chemother; 2005 Mar; 49(3):925-30. PubMed ID: 15728885
[TBL] [Abstract][Full Text] [Related]
7. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
Wu JZ; Yeh LT; Lin CC; Hong Z
Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
[TBL] [Abstract][Full Text] [Related]
8. Absorption, pharmacokinetics and excretion of levovirin in rats, dogs and cynomolgus monkeys.
Lin CC; Luu T; Lourenco D; Yeh LT; Lau JY
J Antimicrob Chemother; 2003 Jan; 51(1):93-9. PubMed ID: 12493792
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolic profiles of [14C]viramidine and [14C]ribavirin in rat and monkey red blood cells and liver.
Lin CC; Lourenco D; Xu G; Yeh LT
Antimicrob Agents Chemother; 2004 May; 48(5):1872-5. PubMed ID: 15105147
[TBL] [Abstract][Full Text] [Related]
10. Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection.
Aora S; Xu C; Teng A; Peterson J; Yeh LT; Gish R; Lau D; Rossi S; Lin CC
J Clin Pharmacol; 2005 Mar; 45(3):275-85. PubMed ID: 15703363
[TBL] [Abstract][Full Text] [Related]
11. Viramidine demonstrates better safety than ribavirin in monkeys but not rats.
Dadgostari S; Xu C; Yeh LT; Lin CC; Vitarella D
Drug Chem Toxicol; 2004 Aug; 27(3):191-211. PubMed ID: 15478943
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
17. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
Tang-Liu DD; Richman JB; Lin P; Selim S
Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
Mukai H; Watanabe S; Morino A
Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans.
Olsen GW; Chang SC; Noker PE; Gorman GS; Ehresman DJ; Lieder PH; Butenhoff JL
Toxicology; 2009 Feb; 256(1-2):65-74. PubMed ID: 19059455
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
Teng R; Girard D; Gootz TD; Foulds G; Liston TE
Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
